Effects of nitric oxide synthesis inhibition on pulmonary gas exchange in hepatopulmonary syndrome

F. P. Gómez, G. P. Martínez, E. Polverino, J. A. Barberà, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain)

Source: Annual Congress 2004 - Pulmonary circulation
Session: Pulmonary circulation
Session type: Thematic Poster Session
Number: 3468

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. P. Gómez, G. P. Martínez, E. Polverino, J. A. Barberà, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain). Effects of nitric oxide synthesis inhibition on pulmonary gas exchange in hepatopulmonary syndrome. Eur Respir J 2004; 24: Suppl. 48, 3468

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of nitric oxide in hepatopulmonary syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 546s
Year: 2006

Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients
Source: Eur Respir J 2009; 34: 138-144
Year: 2009



Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 547s
Year: 2006

Effects on systemic and pulmonary circulation and gas exchange of inhaled L-NAME in hepatopulmonary syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005

Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1386-1395
Year: 2016



Acute vasoresponsiveness to inhaled nitric oxide in sarcoidosis-associated pulmonary hypertension
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008


Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003

Infused nitric oxide in experimental pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 348s
Year: 2007

Role of nitric oxide pathway in pathogenesis of high altitude pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 551s
Year: 2007

Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs
Source: ERJ Open Res 2016
Year: 2016


Increased eNO and pulmonary iNOS expression in eNOS null mice
Source: Eur Respir J 2003; 21: 770-773
Year: 2003



The role of nitric oxide (NO) on sepsis-induced pulmonary apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001

Early detection of emphysema with the nitric oxide diffusion capacity
Source: Eur Respir J 2007; 30: Suppl. 51, 8s
Year: 2007

Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction
Source: Eur Respir J 2003; 21: 19-24
Year: 2003



Haemodynamic testing in primary pulmonary hypertension - effects of nitric oxide, iloprost and oxygen
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001

Replacement of physiologically autoinhaled nitric oxide in intubated patients
Source: Eur Respir J 2003; 21: 677-681
Year: 2003



Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015